United States Healthcare Providers & Services

Chemed Corp (CHE)

Track

Over the last 90 days, Chemed Corp. has seen significant insider selling, with a net value of -$2.45 million. Executives contributed -$2.20 million to this net sell-off. Notably, Kevin J. McNamara, President and CEO, has been involved in multiple large sell transactions and proposed sales. The company's stock has experienced a modest 1.3% increase over the same period.
Stock chart
Ticker: CHE Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
WALSH GEORGE J III
1 sale — total 100,000 USD
Sale 29 May 2026
Value US$3,474,218.56 | Price 218.45 | Shares 76,719
Proposed sale 8 May 2026
Value US$2,216,317.62 | Price 91.15 | Shares 51,639
Sale 8 May 2026
Value US$25,546.80 | Price 425.78 | Shares 60
Sale 1 May 2026
Value US$842,260.00 | Price 421.13 | Shares 2,000
Proposed sale 1 May 2026
Value US$420,000.00 | Price 420.00 | Shares 1,000
Proposed sale 1 May 2026
Value US$419,850.00 | Price 419.85 | Shares 1,000
Sale 27 Mar 2026
Value US$554,055.00 | Price 369.37 | Shares 1,500
Proposed sale 27 Mar 2026
Value US$558,855.00 | Price 372.57 | Shares 1,500
Sale 12 Mar 2026
Value US$806,360.00 | Price 403.18 | Shares 2,000
Proposed sale 12 Mar 2026
Value US$404,790.00 | Price 404.79 | Shares 1,000
Proposed sale 12 Mar 2026
Value US$403,820.00 | Price 403.82 | Shares 1,000
Proposed sale 11 Dec 2025
Value US$405,645.00 | Price 430.62 | Shares 942
Sale 24 Nov 2025
Value US$875,100.00 | Price 437.55 | Shares 2,000
Proposed sale 24 Nov 2025
Value US$876,000.00 | Price 438.00 | Shares 2,000
Proposed sale 26 Sep 2025
Value US$857,107.00 | Price 428.55 | Shares 2,000
Sale 26 Sep 2025
Value US$1,383,840.00 | Price 461.28 | Shares 3,000
Proposed sale 26 Sep 2025
Value US$460,000.00 | Price 460.00 | Shares 1,000
Sale 9 Sep 2025
Value US$69,508.50 | Price 463.39 | Shares 150
Proposed sale 9 Sep 2025
Value US$69,567.00 | Price 463.78 | Shares 150
Proposed sale 5 Aug 2025
Value US$857,460.00 | Price 428.73 | Shares 2,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-29 2026-05-29 S Sale
2.9
WALSH GEORGE J III
Non-Executive Director
76,719 -37.4%
218.45
US$3,474,219 		76,719 -37.4% 218.45 US$3,474,219
2026-05-08 2026-05-08 PrS Proposed sale
2.6
Patrick P. Grace

Director

Non-Executive Director
51,639
91.15
US$2,216,318 		51,639 91.15 US$2,216,318
2026-05-08 2026-05-08 S Sale
2.6
GRACE PATRICK P
Non-Executive Director
47,499 +48.2%
194.49
US$4,428,171 		47,499 +48.2% 194.49 US$4,428,171
2026-05-04 2026-05-01 S Sale
3.2
MCNAMARA KEVIN J

president and CEO

Executive Director
2,000 -2.2%
421.13
US$842,260 		2,000 -2.2% 421.13 US$842,260
2026-05-01 2026-05-01 PrS Proposed sale
3.2
KEVIN MCNAMARA

OFFICER

Officer
1,000
419.85
US$419,850 		1,000 419.85 US$419,850
2026-05-01 2026-05-01 PrS Proposed sale
3.2
MCNAMARA KEVIN J

Officer

Officer
1,000
420.00
US$420,000 		1,000 420.00 US$420,000
2026-03-30 2026-03-27 S Sale
3.2
MCNAMARA KEVIN J

president and CEO

Executive Director
1,500 -1.6%
369.37
US$554,055 		1,500 -1.6% 369.37 US$554,055
2026-03-27 2026-03-27 PrS Proposed sale
3.2
Kevin McNamara

Officer

Officer
1,500
372.57
US$558,855 		1,500 372.57 US$558,855
2026-03-13 2026-03-12 S Sale
3.2
MCNAMARA KEVIN J

president and CEO

Executive Director
2,000 -2.1%
403.18
US$806,360 		2,000 -2.1% 403.18 US$806,360
2026-03-12 2026-03-12 PrS Proposed sale
3.2
Kevin McNamara

Officer

Officer
1,000
403.82
US$403,820 		1,000 403.82 US$403,820
2026-03-12 2026-03-12 PrS Proposed sale
3.2
MCNAMARA KEVIN J

Officer; Director

Executive Director
1,000
404.79
US$404,790 		1,000 404.79 US$404,790
2025-12-11 2025-12-11 PrS Proposed sale
2.8
Nicholas Westfall

former officer

Officer
942
430.62
US$405,645 		942 430.62 US$405,645
2025-11-25 2025-11-24 S Sale
3.2
MCNAMARA KEVIN J

president and CEO

Executive Director
2,000 -2.1%
437.55
US$875,100 		2,000 -2.1% 437.55 US$875,100
2025-11-24 2025-11-24 PrS Proposed sale
3.2
MCNAMARA KEVIN J

Officer; Director

Executive Director
2,000
438.00
US$876,000 		2,000 438.00 US$876,000
2025-09-29 2025-09-26 PrS Proposed sale
3.2
Kevin McNamara

Officer

Officer
2,000
428.55
US$857,107 		2,000 428.55 US$857,107
2025-09-29 2025-09-26 S Sale
3.2
MCNAMARA KEVIN J

president and CEO

Executive Director
3,000 -3.0%
461.28
US$1,383,840 		3,000 -3.0% 461.28 US$1,383,840
2025-09-26 2025-09-26 PrS Proposed sale
3.2
MCNAMARA KEVIN J

Officer; Director

Executive Director
1,000
460.00
US$460,000 		1,000 460.00 US$460,000
2025-09-10 2025-09-09 S Sale
2.6
GRACE PATRICK P
Non-Executive Director
150 -4.2%
463.39
US$69,508 		150 -4.2% 463.39 US$69,508
2025-09-09 2025-09-09 PrS Proposed sale
2.6
Patrick P. Grace

Director

Non-Executive Director
150
463.78
US$69,567 		150 463.78 US$69,567
2025-08-05 2025-08-05 PrS Proposed sale
3.2
MCNAMARA KEVIN J

Officer; Director

Executive Director
2,000
428.73
US$857,460 		2,000 428.73 US$857,460
Explore more

More insider trading research around Chemed Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America